A Premium Reappears for JPMorgan Alerian MLP Index ETN
While investors have flocked to an MLP exchange-traded fund, we recommend sticking with exchange-traded notes for this asset class.
Starting in late March, JPMorgan Alerian MLP Index ETN (AMJ) began trading at a small premium to its net asset value. This week, the premium reached as high as 5% on below-average trading volume. The situation should not come as a surprise--
J.P. Morgan Chase (JPM) capped the creation of new AMJ shares in June 2012, and this decision effectively turned the exchange-traded note into a closed-end product. If demand for AMJ exceeds the shares available, the ETN will trade at a premium to NAV.
As a refresher, when the demand for shares of an exchange-traded fund exceeds the supply on offer, an authorized participant (AP) ordinarily steps in to create new shares. The AP buys the ETF's constituents and delivers them to the ETF's issuer in exchange for shares of the ETF. The opposite process, called a redemption, is when the AP delivers ETF shares in exchange for the underlying stocks. This arbitrage process prevents the price of an ETF from significantly deviating from its NAV. Because ETNs are debt obligations and do not actually own any underlying assets, the creation and redemption process occurs with cash. However, AMJ currently has no creation capability.
Abby Woodham does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.